IRIS UniCatt

D'Alo', Francesco
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.736
EU - Europa 4.889
AS - Asia 2.951
SA - Sud America 509
OC - Oceania 171
AF - Africa 99
Continente sconosciuto - Info sul continente non disponibili 3
Totale 14.358
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.535
DE - Germania 1.721
CN - Cina 1.147
SG - Singapore 1.083
SE - Svezia 678
IT - Italia 650
BR - Brasile 423
GB - Regno Unito 296
UA - Ucraina 293
PL - Polonia 257
FR - Francia 253
FI - Finlandia 162
IN - India 157
IE - Irlanda 156
AU - Australia 149
CA - Canada 137
VN - Vietnam 110
ID - Indonesia 106
RU - Federazione Russa 70
TR - Turchia 69
NL - Olanda 54
HK - Hong Kong 38
AT - Austria 37
JP - Giappone 37
MX - Messico 37
ES - Italia 35
BE - Belgio 26
AR - Argentina 25
CH - Svizzera 25
IR - Iran 25
CI - Costa d'Avorio 23
KR - Corea 23
RO - Romania 23
BD - Bangladesh 21
NZ - Nuova Zelanda 21
ZA - Sudafrica 20
CZ - Repubblica Ceca 18
GR - Grecia 15
HU - Ungheria 15
IL - Israele 15
EG - Egitto 14
IQ - Iraq 14
CO - Colombia 13
AE - Emirati Arabi Uniti 12
DZ - Algeria 12
LT - Lituania 12
BG - Bulgaria 11
EC - Ecuador 11
PK - Pakistan 11
PT - Portogallo 11
MA - Marocco 10
MY - Malesia 10
NO - Norvegia 10
VE - Venezuela 10
DK - Danimarca 9
PY - Paraguay 9
SK - Slovacchia (Repubblica Slovacca) 9
CL - Cile 8
SA - Arabia Saudita 8
UZ - Uzbekistan 8
HR - Croazia 7
DO - Repubblica Dominicana 6
JM - Giamaica 6
TH - Thailandia 6
BA - Bosnia-Erzegovina 5
GE - Georgia 5
KE - Kenya 5
KG - Kirghizistan 5
LB - Libano 5
LV - Lettonia 5
NP - Nepal 5
PE - Perù 5
RS - Serbia 5
AZ - Azerbaigian 4
JO - Giordania 4
MK - Macedonia 4
TN - Tunisia 4
TT - Trinidad e Tobago 4
AL - Albania 3
AM - Armenia 3
BY - Bielorussia 3
EE - Estonia 3
GH - Ghana 3
LK - Sri Lanka 3
ME - Montenegro 3
PS - Palestinian Territory 3
SI - Slovenia 3
TW - Taiwan 3
BB - Barbados 2
BO - Bolivia 2
ET - Etiopia 2
HN - Honduras 2
IS - Islanda 2
LA - Repubblica Popolare Democratica del Laos 2
LY - Libia 2
PR - Porto Rico 2
QA - Qatar 2
SN - Senegal 2
UY - Uruguay 2
A1 - Anonimo 1
Totale 14.340
Salva come PNG Salva come JPEG
Città #
Chandler 638
Singapore 596
Ashburn 388
Beijing 292
Jacksonville 222
Warsaw 216
Munich 193
Houston 166
Nanjing 150
Dublin 148
Dearborn 142
San Mateo 140
Woodbridge 133
Ann Arbor 132
Fairfield 131
Milan 121
New York 114
Wilmington 113
Rome 112
Los Angeles 109
Hangzhou 103
Nürnberg 95
Redwood City 93
Seattle 93
Jakarta 89
Chicago 79
Helsinki 76
Dallas 69
Bremen 67
Hefei 67
Nanchang 59
Boston 57
Cattolica 52
Moscow 51
Lawrence 50
Frankfurt am Main 46
Hanoi 37
London 37
Izmir 36
Marseille 36
Sydney 36
São Paulo 36
Hong Kong 35
Cambridge 33
Kunming 32
The Dalles 32
Brooklyn 31
Guangzhou 31
Ho Chi Minh City 31
Lancaster 29
Shanghai 29
Boardman 26
Portland 26
Toronto 26
Phoenix 25
San Francisco 25
Melbourne 24
Shenyang 24
Abidjan 23
Hyderabad 23
Princeton 23
Adelaide 22
Brisbane 22
Buffalo 22
Tokyo 22
Brussels 21
Santa Clara 21
Kent 20
Changsha 19
Leawood 19
Atlanta 18
Auburn Hills 18
Hebei 18
Redmond 18
Fremont 17
Nuremberg 17
Philadelphia 17
Jiaxing 16
Denver 15
Mountain View 15
San Diego 15
Tianjin 15
University Park 15
Norwalk 14
Poplar 14
San Jose 14
Vienna 14
Wroclaw 14
Zhengzhou 14
Augusta 13
Berlin 13
Kansas City 13
Montreal 13
Seoul 13
Amsterdam 12
Istanbul 12
Pittsburgh 12
Belo Horizonte 11
Cincinnati 11
Jinan 11
Totale 6.768
Salva come PNG Salva come JPEG
Nome #
VITAMIN B12 DEFICIENCY: CORRELATION BETWEEN MTHFR POLYMORPHISMS AND CLINICAL AND LABORATORY FINDINGS 2.853
HIGH-DOSE CHEMOTHERAPY WITH AUTOLOGOUS STEM CELL TRANSPLANTATION IN FIRST LINE TREATMENT FOR HIGH-RISK DIFFUSE LARGE B CELL LYMPHOMA (DLBCL) IN THE RITUXIMAB ERA: AN INTENTION TO TREAT-ANALYSIS 392
Vitamin D deficiency and supplementation in patients with aggressive B-cell lymphomas treated with immunochemotherapy 314
Risk factors for venous thromboembolism in patients with lymphoma requiring hospitalization 306
DNMT1-interacting RNAs block gene-specific DNA methylation 274
PD-L1 expression in peripheral blood granulocytes at diagnosis as prognostic factor in classical Hodgkin lymphoma 252
Quantification of DAPK1 Promoter Methylation in Bone Marrow and Peripheral Blood as a Follicular Lymphoma Biomarker 251
Mutational analysis of bone marrow mesenchymal stromal cells in myeloid malignancies 236
Venous Thromboembolism in Lymphoma: Risk Stratification and Antithrombotic Prophylaxis 210
PTEN/PI3K/AKT PATHWAY DYSREGULATION IN MYELODYSPLASTIC GRANULOCYTES 206
Interleukin-6 plasma levels are modulated by a polymorphism in the NF-κB1 gene and are associated with outcome following rituximab-combined chemotherapy in diffuse large B-cell non-Hodgkin lymphoma. 205
GSK3β down-regulation in Mesenchymal Stem Cells from patients with Myelodysplastic Syndrome. 200
MUTATIONAL ANALYSIS OF BONE MARROW MESENCHIMAL STROMAL CELLS IN MYELOID MALIGNANCIES 198
Anemia in Diffuse Large B cell Non-Hodgkin Lymphoma: The Role of IL-6, Hepcidin and Erythropoietin 191
Anemia in Hodgkin's lymphoma: the role of interleukin-6 and hepcidin 187
CD68+ cell count, early evaluation with PET and plasma TARC levels predict response in Hodgkin lymphoma 187
DEREGULATION OF PI3K/AKT SIGNALING IN BONE MARROW MESENCHIMAL STROMAL CELLS FROM PATIENTS WITH DE NOVO AND THERAPY-RELATED ACUTE MYELOID LEUKEMIA 186
Mutations of epigenetic regulators and of the spliceosome machinery in therapy-related myeloid neoplasms and in acute leukemias evolved from chronic myeloproliferative diseases 164
Reduced BRCA1 expression due to promoter hypermethylation in therapy-related acute myeloid leukaemia 163
Increased risk of acute myeloid leukaemia due to polymorphisms in detoxification and DNA repair enzymes. 162
The viral load of Epstein-Barr virus (EBV) DNA in peripheral blood predicts for biological and clinical characteristics in Hodgkin lymphoma 159
Cell-free circulating DNA in Hodgkin's and non-Hodgkin's lymphomas. 157
Impairment of PI3K/AKT and WNT/β-catenin pathways in bone marrow mesenchymal stem cells isolated from patients with myelodysplastic syndromes 157
Analysis of genome-wide methylation and gene expression induced by 5-aza-2'-deoxycytidine identifies BCL2L10 as a frequent methylation target in acute myeloid leukemia. 156
Response to 5-azacytidine in a patient with relapsed Hodgkin Lymphoma and a therapy-related myelodysplastic syndrome 155
Mutations of epigenetic regulators and of the spliceosome machinery in therapy-related myeloid neoplasms and in acute leukemias evolved from chronic myeloproliferative diseases 155
Clinical significance of interleukin-10 gene polymorphisms and plasma levels in Hodgkin lymphoma 153
Progressive multifocal leukoencephalopathy in patients with follicular lymphoma treated with bendamustine plus rituximab followed by rituximab maintenance 152
Promoter methylation of DAPK1, E-cadherin and thrombospondin-1 in de novo and therapy-related myeloid neoplasms 147
Gene expression profiling of myelodysplastic CD34+ hematopoietic stem cells treated in vitro with decitabine 146
Progressive multifocal leukoencephalopathy in patients with follicular lymphoma treated with bendamustine plus rituximab followed by rituximab maintenance 146
Epigenetic changes in therapy-related MDS/AML 142
Promoter methylation of DAPK1, E-cadherin and thrombospondin-1 in de novo and therapy-related myeloid neoplasms 139
Whole blood EBV-DNA predicts outcome in diffuse large B-cell lymphoma 139
Polymorphisms of detoxification and DNA repair enzymes in myelodyplastic syndromes 138
Interleukin-6 plasma levels are modulated by a polymorphism in the NF-κB1 gene and are associated with outcome following rituximab-combined chemotherapy in diffuse large B-cell non-Hodgkin lymphoma 137
A T cell lymphoblastic lymphoma with mucormycosis as unusual etiology of acute cerebral ischemia 137
Cell-free circulating DNA in Hodgkin's and non-Hodgkin's lymphomas 133
Clinical significance of interleukin-10 gene polymorphisms and plasma levels in Hodgkin lymphoma. 133
Anti CD20-based immunochemotherapy abolishes antibody response to Covid-19 mRNA vaccine in lymphoma patients vaccinated during active first line treatment 132
The neutrophil/lymphocyte ratio ≥3.5 is a prognostic marker in diffuse large B-cell lymphoma: a retrospective analysis from the database of the Italian regional network ‘Rete Ematologica del Lazio per i Linfomi’ (RELLI) 130
DAP-kinase hypermethylation in the bone marrow of patients with follicular lymphoma 126
Intravascular large-B cell lymphoma: when lymphoma is suspected but routine diagnostic work-up is negative. 125
DAP-kinase hypermethylation in the bone marrow of patients with follicular lymphoma. 125
Gene expression profiling of myelodysplastic CD34+ hematopoietic stem cells treated in vitro with decitabine. 123
PU.1 and CEBPA expression in acute myeloid leukemia. 122
Glutathione-S-transferase genotypes influence prognosis in follicular non-Hodgkin's Lymphoma. 121
Invasive fungal infections in chronic lymphoproliferative disorders: a monocentric retrospective study 118
Novel Targets and Advanced Therapies in Diffuse Large B Cell Lymphomas 116
Anemia in diffuse large B-cell non-Hodgkin lymphoma: the role of interleukin-6, hepcidin and erythropoietin. 116
In vitro Effect of Eltrombopag Alone and in Combination With Azacitidine on Megakaryopoiesis in Patients With Myelodysplastic Syndrome 115
Prognostic role of glutathione S-transferase polymorphisms in acute myeloid leukemia. 114
Outcome of therapy-related myeloid neoplasms treated with azacitidine 114
Invasive fungal infections in chronic lymphoproliferative disorders: A monocentric retrospective study 114
Mantle cell lymphoma relapsing at the lymphedematous arm 113
Primary pancreatic lymphoma in a patient with maturity onset diabetes of the young type 3 112
Chemoradiotherapy with temozolomide after high-dose methotrexate for primary CNS lymphoma: a multicenter phase I study of a response-adapted strategy 109
Comorbidity assessment to determine prognosis in older adult patients with classical Hodgkin lymphoma 108
Bax mutations are an infrequent event in indolent lymphomas and in mantle cell lymphoma 107
The prognostic impact of monoclonal immune globulin and free light chain secretion in diffuse large B cell lymphoma (DLBCL) 107
Impairment of PI3K/AKT and WNT/β-catenin pathways in bone marrow mesenchymal stem cells isolated from patients with myelodysplastic syndromes 106
Glutathione-S-transferase genotypes influence prognosis in follicular non-Hodgkin's Lymphoma 105
Enhancing lymphoma diagnosis on core needle biopsies: Integrating immunohistochemistry with flow cytometry 104
Azacitidine in a patient with myelodysplastic syndrome: Impact of switching from a 5-day to the approved 7-day dosing schedule 104
Polymorphism in cytokine genes as prognostic markers in Hodgkin's lymphoma 102
Four doses of unpegylated versus one dose of pegylated filgrastim as supportive therapy in R-CHOP-14 for elderly patients with diffuse large B-cell lymphoma 102
PD-L1 expression in peripheral blood granulocytes at diagnosis as prognostic factor in classical Hodgkin lymphoma 100
Body mass index is not associated with survival outcomes and immune-related adverse events in patients with Hodgkin lymphoma treated with the immune checkpoint inhibitor nivolumab 99
Aggiornamenti di Diagnostica Molecolare in Ematologia 97
Invasive fungal infections in chronic lymphoproliferative disorders: a monocentric retrospective study 97
Burkitt lymphoma as fourth neoplasia in a patient affected by cowden syndrome with a novel PTEN germline pathogenic variant 95
Negative prognostic value of glutathione s-transferase (gstm1 and gstt1) deletions in adult acute myeloid leukemia. 94
Severe cmv infection after chemo-immunotherapy with dose- reduced bendamustine and rituximab in a mantle cell lymphoma old patient 93
Predicting time to treatment in follicular lymphoma on watchful waiting using baseline metabolic tumour burden 91
Frequent downregulation of the transcription factor Foxa2 in lung cancer through epigenetic silencing 76
CAR-T Cell Therapy for Follicular Lymphomas 74
Endoscopic Ultrasound-Guided Fine Needle Biopsy in the Diagnostic Work-Up of Deep-Seated Lymphadenopathies and Spleen Lesions: A Monocentric Experience 68
Secondary Orbital and Intraocular Lymphoma Treated With Immunochemotherapy 67
Mutations of epigenetic regulators and of the spliceosome machinery in therapy-related myeloid neoplasms and in acute leukemias evolved from chronic myeloproliferative diseases 63
Case of metastatic melanoma in bone marrow smear 62
Absence of structural mutations of the BAK gene in B cell lymphomas 62
May we routinely spare hippocampal region in primary central nervous system lymphoma during whole brain radiotherapy? 60
Treatment with Idelalisib in Patients with Relapsed or Refractory Follicular Lymphoma: The Observational Italian Multicenter FolIdela Study 55
In vitro effect of eltrombopag alone and in combination with azacitidine on megakaryopoiesis in patients with myelodysplastic syndrome 49
The Predictive Role of Baseline 18F-FDG PET/CT Radiomics in Follicular Lymphoma on Watchful Waiting: A Preliminary Study 43
Treatment outcomes in elderly patients ≥ 65 years with Large B-Cell Lymphoma (LBCL): a real-world single center experience focusing on potential CD19-CAR-T eligibility in second line 33
Safety and efficacy of SARS-Cov2 neutralizing monoclonal antibodies after stem cell transplant or CAR-T cell infusion 6
Heterogeneous Surface CD79b Expression in Aggressive B-Cell Lymphomas Assessed by Flow Cytometry on Lymph Node Biopsies 2
Totale 14.494
Salva come PNG Salva come JPEG
Categoria #
all - tutte 47.008
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 47.008
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021867 0 0 0 0 114 115 124 33 105 88 247 41
2021/2022871 103 80 13 31 65 36 26 133 51 70 122 141
2022/20231.867 259 261 128 319 114 216 95 141 175 39 74 46
2023/20241.669 54 256 71 92 114 193 81 109 81 151 226 241
2024/20252.804 297 204 269 144 224 113 210 149 325 224 357 288
2025/20262.023 646 223 268 489 397 0 0 0 0 0 0 0
Totale 14.494